Guang‐Shing Cheng

8.1k total citations
63 papers, 1.3k citations indexed

About

Guang‐Shing Cheng is a scholar working on Surgery, Oncology and Epidemiology. According to data from OpenAlex, Guang‐Shing Cheng has authored 63 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Surgery, 22 papers in Oncology and 22 papers in Epidemiology. Recurrent topics in Guang‐Shing Cheng's work include Transplantation: Methods and Outcomes (21 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (18 papers) and Hematopoietic Stem Cell Transplantation (18 papers). Guang‐Shing Cheng is often cited by papers focused on Transplantation: Methods and Outcomes (21 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (18 papers) and Hematopoietic Stem Cell Transplantation (18 papers). Guang‐Shing Cheng collaborates with scholars based in United States, South Africa and France. Guang‐Shing Cheng's co-authors include Steven A. Pergam, Michael Boeckh, Paul J. Martin, Stephanie J. Lee, Kelsey K. Baker, Maresa C. Woodfield, Jesse R. Fann, Christine M. Lee, Sara Marquis and Xing‐Hua Xia and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Guang‐Shing Cheng

57 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Guang‐Shing Cheng United States	21	441	336	286	282	234	63	1.3k
Bonnie Hepburn United States	11	203 0.5×	159 0.5×	219 0.8×	258 0.9×	128 0.5×	19	1.7k
Tauseef Ali United States	17	97 0.2×	126 0.4×	439 1.5×	375 1.3×	129 0.6×	43	1.6k
Hans van der Hoeven Netherlands	16	349 0.8×	293 0.9×	248 0.9×	105 0.4×	73 0.3×	30	1.7k
Bjarni Þjóðleifsson Iceland	28	93 0.2×	300 0.9×	467 1.6×	1.1k 3.7×	144 0.6×	77	2.4k
Gabriele Halwachs‐Baumann Austria	20	162 0.4×	104 0.3×	399 1.4×	143 0.5×	38 0.2×	51	1.4k
Elie Aoun United States	19	137 0.3×	266 0.8×	245 0.9×	573 2.0×	401 1.7×	72	1.4k
Manuel Díaz‐Rubio Spain	33	61 0.1×	93 0.3×	496 1.7×	695 2.5×	214 0.9×	85	2.2k
Kathleen D. Lake United States	23	65 0.1×	96 0.3×	489 1.7×	686 2.4×	172 0.7×	66	2.0k
Idit F. Schwartz Israel	20	77 0.2×	204 0.6×	127 0.4×	148 0.5×	73 0.3×	71	1.8k
Fanny Vardon‐Bounes France	16	83 0.2×	121 0.4×	237 0.8×	114 0.4×	93 0.4×	58	917

Countries citing papers authored by Guang‐Shing Cheng

Since Specialization

Citations

This map shows the geographic impact of Guang‐Shing Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guang‐Shing Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guang‐Shing Cheng more than expected).

Fields of papers citing papers by Guang‐Shing Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guang‐Shing Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guang‐Shing Cheng. The network helps show where Guang‐Shing Cheng may publish in the future.

Co-authorship network of co-authors of Guang‐Shing Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Guang‐Shing Cheng. A scholar is included among the top collaborators of Guang‐Shing Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guang‐Shing Cheng. Guang‐Shing Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bashoura, Lara, Guang‐Shing Cheng, Joe L. Hsu, et al.. (2025). Noninfectious pulmonary complications after hematopoietic cell transplantation: a comprehensive review. Respiratory Medicine. 248. 108336–108336.

Sharifi, Husham, Christian O’Donnell, Laura Johnston, et al.. (2025). Pirfenidone for the treatment of bronchiolitis obliterans syndrome related to chronic graft-versus-host disease. Blood Advances. 9(19). 5024–5037.

Sharifi, Husham, Charlotte Moss, Christian O’Donnell, et al.. (2025). Pirfenidone for the Treatment of Bronchiolitis Obliterans Syndrome After Allogeneic Hematopoietic Cell Transplant: Results from a Single-Arm Extension Trial. American Journal of Respiratory and Critical Care Medicine. 211(Supplement_1). A1133–A1133. 1 indexed citations

DeFilipp, Zachariah, Haesook T. Kim, Guang‐Shing Cheng, et al.. (2024). A phase 2 multicenter trial of ruxolitinib to treat bronchiolitis obliterans syndrome after allogeneic HCT. Blood Advances. 9(2). 244–253. 3 indexed citations

Hill, Joshua A., Yeon Joo Lee, Lisa K. Vande Vusse, et al.. (2024). HHV-6B detection and host gene expression implicate HHV-6B as pulmonary pathogen after hematopoietic cell transplant. Nature Communications. 15(1). 542–542. 8 indexed citations

Lindsay, Julian, Carla S. Walti, Anna B. Halpern, et al.. (2023). Invasive fungal infections after CLAG-M/CLAG chemotherapy for acute myeloid leukemia and high-grade myeloid neoplasms. Blood Advances. 7(13). 3140–3145. 3 indexed citations

Ford, Emily S., William Simmons, Ellora Karmarkar, et al.. (2022). Successful Treatment of Prolonged, Severe Coronavirus Disease 2019 Lower Respiratory Tract Disease in a B cell Acute Lymphoblastic Leukemia Patient With an Extended Course of Remdesivir and Nirmatrelvir/Ritonavir. Clinical Infectious Diseases. 76(5). 926–929. 40 indexed citations

Glanville, Allan R., Christian Benden, Anne Bergeron, et al.. (2022). Bronchiolitis obliterans syndrome after lung or haematopoietic stem cell transplantation: current management and future directions. ERJ Open Research. 8(3). 185–2022. 23 indexed citations

Williams, Kirsten M., Steven Z. Pavletic, Stephanie J. Lee, et al.. (2022). Prospective Phase II Trial of Montelukast to Treat Bronchiolitis Obliterans Syndrome after Hematopoietic Cell Transplantation and Investigation into Bronchiolitis Obliterans Syndrome Pathogenesis. Transplantation and Cellular Therapy. 28(5). 264.e1–264.e9. 11 indexed citations

10.

Sharifi, Husham, Christian O’Donnell, Clark G. Owyang, et al.. (2022). The safety and tolerability of pirfenidone for bronchiolitis obliterans syndrome after hematopoietic cell transplant (STOP-BOS) trial. Bone Marrow Transplantation. 57(8). 1319–1326. 13 indexed citations

11.

Walti, Carla S., Guang‐Shing Cheng, Ajay K. Gopal, & Joshua A. Hill. (2021). Progressive Pulmonary Infiltrates in a Man with Mediastinal Lymphoma. Annals of the American Thoracic Society. 18(5). 884–888.

12.

Ford, Emily S., Elizabeth R. Duke, Guang‐Shing Cheng, et al.. (2021). Outcomes of Hematopoietic Cell Transplantation in Patients with Mixed Response to Pretransplantation Treatment of Confirmed or Suspected Invasive Fungal Infection. Transplantation and Cellular Therapy. 27(8). 684.e1–684.e9. 3 indexed citations

13.

Cheng, Guang‐Shing, et al.. (2020). The novel coronavirus disease (COVID‐19) complicated by pulmonary embolism and acute respiratory distress syndrome. Journal of Medical Virology. 92(10). 2205–2208. 4 indexed citations

14.

Verdial, Francys C., David K. Madtes, Guang‐Shing Cheng, et al.. (2019). Multidisciplinary Team-Based Management of Incidentally Detected Lung Nodules. CHEST Journal. 157(4). 985–993. 19 indexed citations

15.

Cheng, Guang‐Shing, Louise Bondeelle, Ted Gooley, et al.. (2019). Azithromycin Use and Increased Cancer Risk among Patients with Bronchiolitis Obliterans after Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(2). 392–400. 20 indexed citations

16.

Fatobene, Giancarlo, Barry E. Storer, Rachel B. Salit, et al.. (2018). Disability related to chronic graft -versus-host disease after alternative donor hematopoietic cell transplantation. Haematologica. 104(4). 835–843. 20 indexed citations

17.

Cheng, Guang‐Shing, Zach Stednick, David K. Madtes, et al.. (2016). Decline in the Use of Surgical Biopsy for Diagnosis of Pulmonary Disease in Hematopoietic Cell Transplantation Recipients in an Era of Improved Diagnostics and Empirical Therapy. Biology of Blood and Marrow Transplantation. 22(12). 2243–2249. 18 indexed citations

18.

Cheng, Guang‐Shing, Barry E. Storer, Jason W. Chien, et al.. (2016). Lung Function Trajectory in Bronchiolitis Obliterans Syndrome after Allogeneic Hematopoietic Cell Transplant. Annals of the American Thoracic Society. 13(11). 1932–1939. 49 indexed citations

19.

Bussel, J B, Guang‐Shing Cheng, Mohammad Saleh, et al.. (2007). Eltrombopag, an oral platelet growth factor, for treatment of chronic immune thrombocytopenic purpura (ITP): A randomized, double-blind, placebo-controlled trial. 5. 66–67. 1 indexed citations

20.

Xia, Xing‐Hua, et al.. (2006). Behavioral, neurochemical and neuroendocrine effects of the ethanolic extract from Curcuma longa L. in the mouse forced swimming test. Journal of Ethnopharmacology. 110(2). 356–363. 104 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact